ReviewFrontiers in immunology2026
Inflammation, cell death, and lncRNAs: unraveling the mechanisms of sepsis-associated acute kidney injury.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Targeting integrated cell death networks in sepsis‑associated acute kidney injury: Shared regulatory nodes and diet‑related small molecule modulation (Review).International journal of molecular medicine · 2026Review
- Linear dose-response relationship between vancomycin trough concentration and acute kidney injury in sepsis: effect modification by hyperlactatemia.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis-associated acute kidney injury (SA-AKI) is a common and devastating complication of sepsis and remains a major contributor to morbidity and mortality in critically ill patients. Despite advances in supportive care, effective pharmacological therapies are still lacking, largely due to the complex and multifactorial pathogenesis of SA-AKI. Accumulating evidence indicates that dysregulated inflammation, oxidative stress, and multiple forms of programmed cell death-including apoptosis, pyroptosis, ferroptosis, and autophagy-are central drivers of renal tubular and endothelial dysfunction during sepsis. Recent studies have identified long non-coding RNAs (lncRNAs) as critical regulators of these pathogenic processes. Through competing endogenous RNA networks or direct interactions with proteins, lncRNAs modulate inflammatory signaling, oxidative stress responses, and cell fate decisions. This review summarizes current mechanistic insights into lncRNA-mediated regulatory networks in SA-AKI, highlights representative molecular axes defined in experimental models, and discusses the translational potential of lncRNAs as diagnostic biomarkers or therapeutic targets. Importantly, lncRNAs exhibit a context-dependent duality, acting as either pathogenic amplifiers or protective modulators of renal injury, underscoring both their biological complexity and clinical relevance in SA-AKI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.